Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

PZ-128

Product Specifications

UNSPSC Description

PZ-128 (P1pal-7), a cell-penetrating lipopeptide pepducin, is a first-in-class, specific and reversible protease-activated receptor-1 (PAR1) antagonist. PZ-128 targets the cytoplasmic surface of PAR1 and interrupts signaling to internally-located G (PAR1-G) proteins. PZ-128 has antiplatelet, anti-metastatic, anti-angiogenic and anticancer effects[1][2][3][4].

Target Antigen

Protease Activated Receptor (PAR)

Type

Reference compound

Related Pathways

GPCR/G Protein

Applications

Cancer-programmed cell death

Field of Research

Cancer; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/pz-128.html

Purity

99.47

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

CCCCCCCCCCCCCCCC(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](CO)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C)C(N[C@@H](CC(C)C)C(N[C@H](C(N)=O)CC1=CC=CC=C1)=O)=O)=O)=O)=O)=O)=O

Molecular Weight

1086.46

References & Citations

[1]Anika Agarwal, et al. Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer. Mol Cancer Ther. 2008 Sep;7(9):2746-57.|[2]Lidija Covic, et al. Protease-Activated Receptor 1 as Therapeutic Target in Breast, Lung, and Ovarian Cancer: Pepducin Approach. Int J Mol Sci. 2018 Jul 31;19(8):2237.|[3]Paul A Gurbel, et al. Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease. Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):189-97.|[4]Ping Zhang, et al. Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducin. Circulation. 2012 Jul 3;126(1):83-91.

Shipping Conditions

Blue Ice

Storage Conditions

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-107146/PZ-128-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-107146/PZ-128-SDS-MedChemExpress.pdf

Clinical Information

Phase 2

CAS Number

371131-16-7

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

POLR1D (DNA-directed RNA Polymerases I and III Subunit RPAC2, AC19, DNA-directed RNA Polymerase I Subunit D, RNA Polymerase I 16kD Subunit, RPC16, hRPA19, FLJ20616, MGC9850)
MBS6002829-01 0.1 mg

POLR1D (DNA-directed RNA Polymerases I and III Subunit RPAC2, AC19, DNA-directed RNA Polymerase I Subunit D, RNA Polymerase I 16kD Subunit, RPC16, hRPA19, FLJ20616, MGC9850)

Ask
View Details
POLR1D (DNA-directed RNA Polymerases I and III Subunit RPAC2, AC19, DNA-directed RNA Polymerase I Subunit D, RNA Polymerase I 16kD Subunit, RPC16, hRPA19, FLJ20616, MGC9850)
MBS6002829-02 5x 0.1 mg

POLR1D (DNA-directed RNA Polymerases I and III Subunit RPAC2, AC19, DNA-directed RNA Polymerase I Subunit D, RNA Polymerase I 16kD Subunit, RPC16, hRPA19, FLJ20616, MGC9850)

Ask
View Details
CD1E Peptide - C-terminal region
MBS3240916-01 0.1 mg

CD1E Peptide - C-terminal region

Ask
View Details
CD1E Peptide - C-terminal region
MBS3240916-02 5x 0.1 mg

CD1E Peptide - C-terminal region

Ask
View Details
Mouse Monoclonal ACBD6 Antibody (4A9D5E9)
NBP3-06614-100ul 100 µL

Mouse Monoclonal ACBD6 Antibody (4A9D5E9)

Ask
View Details
KRT4 (Keratin, Type II Cytoskeletal 4, Cytokeratin-4, CK-4, Keratin-4, K4, CYK4, Type-II Keratin Kb4, FLJ31692) APC
MBS6137344-01 0.1 mL

KRT4 (Keratin, Type II Cytoskeletal 4, Cytokeratin-4, CK-4, Keratin-4, K4, CYK4, Type-II Keratin Kb4, FLJ31692) APC

Ask
View Details